Literature DB >> 3966335

Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.

D J Wilber, J J Lynch, D Montgomery, B R Lucchesi.   

Abstract

The relationship between inducible ventricular tachycardia in the convalescent phase of myocardial infarction and subsequent spontaneous ventricular fibrillation is uncertain. Thirty conscious instrumented dogs underwent programmed ventricular stimulation 5 days after anterior infarction; 15 had inducible ventricular tachycardia and 15 were noninducible. Following programmed ventricular stimulation, the application of a 150 uA current to the intima of the proximal circumflex artery initiated intimal damage, thrombosis, and acute ischemia of the posterolateral wall. After 20 minutes of ischemia, 73% inducible and 15% noninducible animals developed ventricular fibrillation (p less than 0.005) without previous hypotension. At 24 hours, 7% inducible and 85% noninducible animals survived (p less than 0.001). Anterior infarct size (percentage of left ventricular mass) was much larger in inducible (24.7 +/- 1.7%) than in noninducible (5.3 +/- 1.1%) (p less than 0.001) animals. Inducible ventricular tachycardia following infarction was highly predictive of spontaneous ventricular fibrillation during a later ischemic episode in this model. The mass of previously injured myocardium was a critical determinant of both.

Entities:  

Mesh:

Year:  1985        PMID: 3966335     DOI: 10.1016/0002-8703(85)90409-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Myocardial Viability on Cardiac Magnetic Resonance.

Authors:  Ana Luiza Mansur Souto; Rafael Mansur Souto; Isabella Cristina Resende Teixeira; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2017-05       Impact factor: 2.000

2.  Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.

Authors:  Zsofia Lenkey; Akos Varga-Szemes; Tamas Simor; Rob J van der Geest; Robert Kirschner; Levente Toth; Tamas Bodnar; Brigitta C Brott; Ada Elgavish; Gabriel A Elgavish
Journal:  J Magn Reson Imaging       Date:  2015-09-10       Impact factor: 4.813

3.  Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction.

Authors:  Jason Ng; Jason T Jacobson; Justin K Ng; David Gordon; Daniel C Lee; James C Carr; Jeffrey J Goldberger
Journal:  J Am Coll Cardiol       Date:  2012-05-23       Impact factor: 24.094

4.  Relationship of non-invasive quantification of myocardial blood flow to arrhythmic events in patients with implantable cardiac defibrillators.

Authors:  Michael Ghannam; Krasimira Mikhova; Hong Jun Yun; John J Lazarus; Matthew Konerman; Ashraf Saleh; Richard L Weinberg; Ryan Cunnane; Ravi V Shah; Keri M Hiller; Edward P Ficaro; James R Corbett; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2017-07-07       Impact factor: 5.952

5.  Atenolol, but not mexiletine, protects against stimulus-induced ventricular tachycardia in a chronic canine model.

Authors:  A C Uprichard; D W Harron
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

6.  H2-receptor antagonism is not pro-arrhythmic in a chronic canine model.

Authors:  A C Uprichard; D W Harron
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

7.  Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.

Authors:  K Krejcy; G Krumpl; H Todt; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

8.  Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy.

Authors:  Hajime Yokota; Shahriar Heidary; Chandra K Katikireddy; Patricia Nguyen; John M Pauly; Michael V McConnell; Phillip C Yang
Journal:  J Cardiovasc Magn Reson       Date:  2008-04-09       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.